Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06859151

DNA Methylation and the Increased Risk of Cervical Cancer Development

The Role of the Genital Tract Microbiota in Cervical Epithelial Cell DNA Methylation and the Increased Risk of Cervical Cancer Development

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Zhujiang Hospital · Academic / Other
Sex
Female
Age
15 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the correlation between reproductive tract microbiota and DNA methylation in cervical epithelial cells, as well as its impact on the development of cervical cancer, through a paired case-control clinical study

Detailed description

This study is a multicenter matched case-control study. The inclusion and exclusion criteria are verified by collecting HPV test results, TCT examination results, and for the case group, participants' histopathological results are also collected. Participants who meet the inclusion and exclusion criteria have their HPV DNA test original secretion samples and TCT examination original cervical scrape cell samples (preserved in RNA preservative solution) collected. Enrollment involves dividing the samples into a discovery cohort of 800 cases and a validation cohort of 1200 cases. The discovery cohort undergoes multi-target DNA methylation testing, STDs pathogen testing, HPV E6/E7 testing, and metagenomic sequencing; the validation cohort undergoes PCR validation of DNA methylation sites related to cervical cancer, STDs pathogen testing, HPV E6/E7 testing, and metagenomic sequencing

Conditions

Interventions

TypeNameDescription
OTHERReproductive tract microbiotaReproductive tract microbiota

Timeline

Start date
2025-03-20
Primary completion
2025-12-30
Completion
2026-12-30
First posted
2025-03-05
Last updated
2025-03-05

Source: ClinicalTrials.gov record NCT06859151. Inclusion in this directory is not an endorsement.